Antihyperlipidemic Activity of the Ethyl-acetate Fraction of Stereospermum Suaveolens in Streptozotocin-induced Diabetic Rats

Journal of Pharmacopuncture
Balasubramanian ThirumalaisamyTapan Kumar Chatterjee

Abstract

Dyslipidemia in diabetes mellitus is a significant risk factor for the development of cardiovascular complications. The aim of this study was to evaluate the effect of the ethyl-acetate fraction of an ethanolic extract from Streospermum suaveolens on lipid metabolism in streptozotocin (STZ)-induced diabetic rats. Diabetes was induced by intraperitonial injection of STZ (50 mg/kg). Diabetic rats were treated with an ethyl-acetate fraction orally at doses of 200 and 400 mg/kg daily for 14 days. On the 15(th) day, serum lipid profiles, such as total cholesterol (TC), triglycerides (TG), low-density lipoprotein (LDL), and high-density lipoprotein (HDL), were estimated in experimental rats. The atherogenic (AI) and the coronary risk (CRI) indices were also evaluated. The ethyl-acetate fraction at doses of 200 and 400 mg/kg significantly (P< 0.001) and dose-dependently reduced serum cholesterol, triglycerides and LDL, but increased HDL towards near normal levels as compared to diabetic control rats. The fraction also significantly (P< 0.001) lowered the atherogenic index (AI) and coronary risk index (CAI) in a dose-dependent manner. The present study demonstrated that the ethyl-acetate fraction of Stereospermum suaveolens exhibits a ...Continue Reading

References

Apr 1, 1987·Journal of Pharmaceutical Sciences·O SiddiquiY W Chien
May 1, 1988·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·R D AbbottW P Castelli
Mar 1, 1996·Diabetes Care·D GiuglianoG Paolisso
Jul 16, 2003·Acta Diabetologica·M L Koschinsky, S M Marcovina
Aug 7, 2003·Journal of Ethnopharmacology·A N NagappaJiwan Singh
Sep 13, 2003·Arteriosclerosis, Thrombosis, and Vascular Biology·Laura CalabresiGuido Franceschini
Oct 31, 2003·Journal of Medicinal Food·R SaravananK V Pugalendi
Aug 17, 2004·The Medical Clinics of North America·W H Wilson TangJames B Young
Mar 2, 2005·Nature Reviews. Drug Discovery·Patrick Linsel-Nitschke, Alan R Tall
Nov 2, 2005·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Richard W Nesto
Oct 10, 2006·Phytochemistry·Mohammad R HaqueMohammad A Rashid
Sep 25, 2007·Journal of Ethnopharmacology·Santosh Kumar SinghGeeta Watal
Apr 3, 2009·American Indian and Alaska Native Mental Health Research : the Journal of the National Center·Jay H ShoreSpero M Manson

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
glycosylation

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Cardiovascular Disorder in Diabetes

Diabetes is associated with an increased risk of cardiovascular disorders and heart failure. Discover the latest research here.